Many individuals seek treatment after experiencing persistent neuropathy symptoms and finding limited relief from general pain medications
Unlike other GHRPs, Ipamorelin does not affect the release of cortisol, acetylcholine, prolactin, or aldosterone, thus minimizing the adverse side effects of other growth hormone therapies, such as increased hunger
While promising, more human studies are needed to confirm its effects
[10] Patients should have thyroid function assessed and corrected prior to and during sermorelin therapy to ensure effectiveness
Supports structured energy intake reduction research: By activating satiety circuits and slowing digestion, Cagrilintide reduces caloric intake in controlled experimental settings
Nevertheless, timely treatment with appropriate vitamin supplementation early in life can effectively control seizures and even restore patients to normalcy